In conclusion, we demonstrated in this exploratory study that complete response of DCIS to NST can be achieved in almost half of the patients with confirmed DCIS adjacent to HER2-positive IBC in pre-NST biopsies. Here, ERBB2 is linked to ductal breast carcinoma in situ.